Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ramos-Casals, M; Font, J; Garcia-Carrasco, M; Calvo, J; Places, L; Padilla, O; Cervera, R; Bowen, MA; Lozano, F; Ingelmo, M
   High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjogren's syndrome
   RHEUMATOLOGY
   
   M. Ramos-Casals et al., "High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjogren's syndrome", RHEUMATOLOG, 40(9), 2001, pp. 1056-1059
2. Font, J; Ramos-Casals, M; Cervera, R; Garcia-Carrasco, M; Torras, A; Siso, A; Darnell, A; Ingelmo, M
   Cardiovascular risk factors and the long-term outcome of lupus nephritis
   QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
   
   J. Font et al., "Cardiovascular risk factors and the long-term outcome of lupus nephritis", QJM-MON J A, 94(1), 2001, pp. 19-26
3. Carmona, F; Font, J; Azulay, M; Creus, M; Fabregues, F; Cervera, R; Puerto, B; Balasch, J
   Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
   
   F. Carmona et al., "Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis", AM J REPROD, 46(4), 2001, pp. 274-279
4. Gregoric, ID; Tamez, D; Karabulut, MN; Cervera, R; Conger, J; Eya, K; Lapeyre, D; Radovancevic, B; Frazier, OH
   Aortic valve implantation in the calf: A successful approach using Heartport (R) cannulation and minimally invasive techniques
   JOURNAL OF HEART VALVE DISEASE
   
   I.D. Gregoric et al., "Aortic valve implantation in the calf: A successful approach using Heartport (R) cannulation and minimally invasive techniques", J HEART V D, 10(5), 2001, pp. 675-680
5. Garcia-Carrasco, M; Font, J; Filella, X; Cervera, R; Ramos-Casals, M; Siso, A; Aymami, A; Ballesta, AM; Ingelmo, M
   Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren'ssyndrome: Correlation with clinical and immunological features
   CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
   
   M. Garcia-Carrasco et al., "Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren'ssyndrome: Correlation with clinical and immunological features", CLIN EXP RH, 19(4), 2001, pp. 411-415
6. Miret, C; Font, J; Molina, R; Garcia-Carrasco, M; Filella, X; Ramos, M; Cervera, R; Ballesta, A; Ingelmo, M
   Relationship of oncogenes (sFas, bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus
   ANTICANCER RESEARCH
   
   C. Miret et al., "Relationship of oncogenes (sFas, bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus", ANTICANC R, 21(4B), 2001, pp. 3053-3059
7. Espinosa, G; Tassies, D; Font, J; Munoz-Rodriguez, FJ; Cervera, R; Ordinas, A; Reverter, JC; Ingelmo, M
   Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis
   SEMINARS IN ARTHRITIS AND RHEUMATISM
   
   G. Espinosa et al., "Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis", SEM ARTH RH, 31(1), 2001, pp. 12-20
8. Garcia-Carrasco, M; Ramos-Casals, M; Cervera, R; Trejo, O; Yague, J; Siso, A; Jimenez, S; de la Red, G; Font, J; Ingelmo, M
   Cryoglobulinemia in systemic lupus erythematosus: Prevalence and clinical characteristics in a series of 122 patients
   SEMINARS IN ARTHRITIS AND RHEUMATISM
   
   M. Garcia-Carrasco et al., "Cryoglobulinemia in systemic lupus erythematosus: Prevalence and clinical characteristics in a series of 122 patients", SEM ARTH RH, 30(5), 2001, pp. 366-373
9. Cervera, R
   The epidemiology and significance of autoimmune diseases in health care
   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
   
   R. Cervera, "The epidemiology and significance of autoimmune diseases in health care", SC J CL INV, 61, 2001, pp. 27-30
10. Espinosa, G; Font, J; Garcia-Pagan, JC; Tassies, D; Reverter, JC; Gaig, C; Cervantes, F; Cervera, R; Bosch, J; Ingelmo, M
    Budd-Chiari syndrome secondary to antiphospholipid syndrome - Clinical andimmunologic characteristics of 43 patients
    MEDICINE
    
    G. Espinosa et al., "Budd-Chiari syndrome secondary to antiphospholipid syndrome - Clinical andimmunologic characteristics of 43 patients", MEDICINE, 80(6), 2001, pp. 345-354
11. Asherson, RA; Cervera, R; Piette, JC; Shoenfeld, Y; Espinosa, G; Petri, MA; Lim, E; Lau, TC; Gurjal, A; Jedryka-Goral, A; Chwalinska-Sadowska, H; Dibner, RJ; Rojas-Rodriguez, J; Garcia-Carrasco, M; Grandone, JT; Parke, AL; Barbosa, P; Vasconcelos, C; Ramos-Casals, M; Font, J; Ingelmo, M
    Catastrophic antiphospholipid syndrome - Clues to the pathogenesis from a series of 80 patients
    MEDICINE
    
    R.A. Asherson et al., "Catastrophic antiphospholipid syndrome - Clues to the pathogenesis from a series of 80 patients", MEDICINE, 80(6), 2001, pp. 355-377
12. Trejo, O; Ramos-Casals, M; Garcia-Carrasco, M; Yague, J; Jimenez, S; De La Red, G; Cervera, R; Font, J; Ingelmo, M
    Cryoglobulinemia - Study of etiologic factors and clinical and immunologicfeatures in 443 patients from a single center
    MEDICINE
    
    O. Trejo et al., "Cryoglobulinemia - Study of etiologic factors and clinical and immunologicfeatures in 443 patients from a single center", MEDICINE, 80(4), 2001, pp. 252-262
13. Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Rosas, J; Trejo, O; de la Red, G; Sanchez-Tapias, JM; Font, J; Ingelmo, M
    Hepatitis C virus infection mimicking primary Sjogren syndrome - A clinical and immunologic description of 35 cases
    MEDICINE
    
    M. Ramos-Casals et al., "Hepatitis C virus infection mimicking primary Sjogren syndrome - A clinical and immunologic description of 35 cases", MEDICINE, 80(1), 2001, pp. 1-8
14. Cervera, A; Espinosa, G; Cervera, R; Font, J; Ingelmo, M
    Cardiac toxicity secondary to long term treatment with chloroquine
    ANNALS OF THE RHEUMATIC DISEASES
    
    A. Cervera et al., "Cardiac toxicity secondary to long term treatment with chloroquine", ANN RHEUM D, 60(3), 2001, pp. 301-301
15. Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Font, J
    Is hepatitis C virus a sialotropic virus?
    AMERICAN JOURNAL OF PATHOLOGY
    
    M. Ramos-Casals et al., "Is hepatitis C virus a sialotropic virus?", AM J PATH, 159(4), 2001, pp. 1593-1594
16. Asherson, RA; Cervera, R
    The catastrophic antiphospholipid syndrome: A review of pathogenesis, clinical features and treatment
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    R.A. Asherson e R. Cervera, "The catastrophic antiphospholipid syndrome: A review of pathogenesis, clinical features and treatment", ISR MED ASS, 2(4), 2000, pp. 268-273
17. Asherson, RA; Cervera, R
    Catastrophic antiphospholipid syndrome
    CURRENT OPINION IN HEMATOLOGY
    
    R.A. Asherson e R. Cervera, "Catastrophic antiphospholipid syndrome", CURR OPIN H, 7(5), 2000, pp. 325-329
18. Segui, J; Ramos-Casals, M; Garcia-Carrasco, M; de Flores, T; Cervera, R; Valdes, M; Font, J; Ingelmo, M
    Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease
    LUPUS
    
    J. Segui et al., "Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease", LUPUS, 9(8), 2000, pp. 584-588
19. Ramos-Casals, M; Trejo, O; Garcia-Carrasco, M; Cervera, R; Font, J
    Mixed cryoglobulinemia: new concepts
    LUPUS
    
    M. Ramos-Casals et al., "Mixed cryoglobulinemia: new concepts", LUPUS, 9(2), 2000, pp. 83-91
20. Cervera, R; Font, J; Ramos-Casals, M; Garcia-Carrasco, M; Rosas, J; Morla, RM; Munoz, FJ; Artigues, A; Pallares, L; Ingelmo, M
    Primary Sjogren's syndrome in men: clinical and immunological characteristics
    LUPUS
    
    R. Cervera et al., "Primary Sjogren's syndrome in men: clinical and immunological characteristics", LUPUS, 9(1), 2000, pp. 61-64
21. Cervera, R
    Recent advances in antiphospholipid antibody-related valvulopathies
    JOURNAL OF AUTOIMMUNITY
    
    R. Cervera, "Recent advances in antiphospholipid antibody-related valvulopathies", J AUTOIMMUN, 15(2), 2000, pp. 123-125
22. Munoz-Rodriguez, FJ; Reverter, JC; Font, J; Tassies, D; Cervera, R; Espinosa, G; Carmona, F; Balasch, J; Ordinas, A; Ingelmo, M
    Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome
    HAEMATOLOGICA
    
    F.J. Munoz-Rodriguez et al., "Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome", HAEMATOLOG, 85(6), 2000, pp. 632-637
23. Rojas-Rodriguez, J; Garcia-Carrasco, M; Ramos-Casals, M; Enriquez-Coronel, G; Colchero, C; Cervera, R; Font, J
    Catastrophic antiphospholipid syndrome: Clinical description and triggering factors in 8 patients
    JOURNAL OF RHEUMATOLOGY
    
    J. Rojas-Rodriguez et al., "Catastrophic antiphospholipid syndrome: Clinical description and triggering factors in 8 patients", J RHEUMATOL, 27(1), 2000, pp. 238-240
24. Ramos-Casals, M; Cervera, R; Garcia-Carrasco, M; Vidal, J; Trejo, O; Jimenez, S; Costa, J; Font, J; Ingelmo, M
    Cytopenia and past human parvovirus B19 infection in patients with primarySjogren's syndrome
    SEMINARS IN ARTHRITIS AND RHEUMATISM
    
    M. Ramos-Casals et al., "Cytopenia and past human parvovirus B19 infection in patients with primarySjogren's syndrome", SEM ARTH RH, 29(6), 2000, pp. 373-378
25. Cortes, T; Becerra, Y; Cervera, R
    Swap compression: resurrecting old ideas
    SOFTWARE-PRACTICE & EXPERIENCE
    
    T. Cortes et al., "Swap compression: resurrecting old ideas", SOFTW PR EX, 30(5), 2000, pp. 567-587
26. Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Gaya, J; Halperin, I; Ubieto, I; Aymami, A; Morla, RM; Font, J; Ingelmo, M
    Thyroid disease in primary Sjogren syndrome - Study in a series of 160 patients
    MEDICINE
    
    M. Ramos-Casals et al., "Thyroid disease in primary Sjogren syndrome - Study in a series of 160 patients", MEDICINE, 79(2), 2000, pp. 103-108
27. Espinosa, G; Munoz-Rodriguez, FJ; Cervera, R; Font, J
    The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome
    MEDICINA CLINICA
    
    G. Espinosa et al., "The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome", MED CLIN, 115(9), 2000, pp. 357-358
28. Garcia-Carrasco, M; Ramos-Casals, M; Cervera, R; Font, J
    Primary Sjogren syndrome and lymphoproliferation
    MEDICINA CLINICA
    
    M. Garcia-Carrasco et al., "Primary Sjogren syndrome and lymphoproliferation", MED CLIN, 114(19), 2000, pp. 740-746
29. Font, J; Pizcueta, P; Ramos-Casals, M; Cervera, R; Garcia-Carrasco, M; Navarro, M; Ingelmo, M; Engel, P
    Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    J. Font et al., "Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)", CLIN EXP IM, 119(1), 2000, pp. 169-174
30. Ramos-Casals, M; Font, J; Garcia-Carrasco, M; Cervera, R; Jimenez, S; Trejo, O; De la Red, G; Sanchez-Tapias, JM; Ingelmo, M
    Hepatitis C virus infection mimicking systemic lupus erythematosus - Studyof hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus
    ARTHRITIS AND RHEUMATISM
    
    M. Ramos-Casals et al., "Hepatitis C virus infection mimicking systemic lupus erythematosus - Studyof hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus", ARTH RHEUM, 43(12), 2000, pp. 2801-2806
31. Tassies, D; Espinosa, G; Munoz-Rodriguez, FJ; Freire, C; Cervera, R; Monteagudo, J; Maragall, S; Escolar, G; Ingelmo, M; Ordinas, A; Font, J; Reverter, JC
    The 4G/5G polymorphism of the type 1 plasminogen activator-inhibitor gene and thrombosis in patients with antiphospholipid syndrome
    ARTHRITIS AND RHEUMATISM
    
    D. Tassies et al., "The 4G/5G polymorphism of the type 1 plasminogen activator-inhibitor gene and thrombosis in patients with antiphospholipid syndrome", ARTH RHEUM, 43(10), 2000, pp. 2349-2358
32. Garcia-Carrasco, M; Pizcueta, P; Cervera, R; Ramos-Casals, M; Siso, A; de la Red, G; Ingelmo, M; Font, J; Engel, P
    Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjogren's syndrome
    ANNALS OF THE RHEUMATIC DISEASES
    
    M. Garcia-Carrasco et al., "Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjogren's syndrome", ANN RHEUM D, 59(4), 2000, pp. 297-299
33. Font, J; Jimenez, S; Cervera, R; Garcia-Carrasco, M; Ramos-Casals, M; Campdelacreu, J; Ingelmo, M
    Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases
    ANNALS OF THE RHEUMATIC DISEASES
    
    J. Font et al., "Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases", ANN RHEUM D, 59(11), 2000, pp. 920-923
34. Font, J; Cervera, R
    Cardiac manifestations in the antiphospholipid syndrome
    HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME
    
    J. Font e R. Cervera, "Cardiac manifestations in the antiphospholipid syndrome", HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 32-42
35. Morla, RM; Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Font, J; Bruguera, M; Rojas-Rodriguez, J; Ingelmo, M
    Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature
    LUPUS
    
    R.M. Morla et al., "Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature", LUPUS, 8(2), 1999, pp. 160-163
36. Garcia-Carrasco, M; Cervera, R; Rosas, J; Ramos-Casals, M; Morla, RM; Siso, A; Jimenez, S; Pallares, L; Font, J; Ingelmo, M
    Primary Sjogren's syndrome in the elderly: clinical and immunological characteristics
    LUPUS
    
    M. Garcia-Carrasco et al., "Primary Sjogren's syndrome in the elderly: clinical and immunological characteristics", LUPUS, 8(1), 1999, pp. 20-23
37. Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Font, J
    Sjogren's syndrome and hepatitis C virus
    CLINICAL RHEUMATOLOGY
    
    M. Ramos-Casals et al., "Sjogren's syndrome and hepatitis C virus", CLIN RHEUMA, 18(2), 1999, pp. 93-100
38. Galeazzi, M; Morozzi, G; Sebastiani, GD; Bellisai, F; Marcolongo, R; Cervera, R; Garrido, ED; Nebro, AF; Houssiau, F; Goral, AJ; Mathieu, A; Papasteriades, C; Piette, JC; Scorza, R; Smolen, J
    Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies (vol 16, pg 541, 1998)
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    M. Galeazzi et al., "Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies (vol 16, pg 541, 1998)", CLIN EXP RH, 17(1), 1999, pp. 141-141
39. Galeazzi, M; Bellisai, F; Sebastiani, GD; Morozzi, G; Marcolongo, R; Cervera, R; Garrido, ED; Nebro, AF; Houssiau, F; Goral, AJ; Mathieu, A; Papasteriades, C; Piette, JC; Scorza, R; Smolen, J
    Association of 16/6 and SA1 anti-DNA idiotypes with antibodies and clinical manifestations in a large cohort of SLE patients (vol 16, pg 717, 1998)
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    M. Galeazzi et al., "Association of 16/6 and SA1 anti-DNA idiotypes with antibodies and clinical manifestations in a large cohort of SLE patients (vol 16, pg 717, 1998)", CLIN EXP RH, 17(1), 1999, pp. 141-141
40. Carmona, F; Font, J; Cervera, R; Munoz, F; Cararach, V; Balasch, J
    Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus. A study of 60 cases
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    F. Carmona et al., "Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus. A study of 60 cases", EUR J OB GY, 83(2), 1999, pp. 137-142
41. Miret, C; Font, J; Molina, R; Garcia-Carrasco, M; Filella, X; Ramos, M; Cervera, R; Ballesta, A; Ingelmo, M
    BCL-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemiclupus erythematosus disease activity
    ANTICANCER RESEARCH
    
    C. Miret et al., "BCL-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemiclupus erythematosus disease activity", ANTICANC R, 19(4B), 1999, pp. 3073-3076
42. Munoz-Rodriguez, FJ; Tassies, D; Font, J; Reverter, JC; Cervera, R; Sanchez-Tapias, JM; Mazzara, R; Ordinas, A; Ingelmo, M
    Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome
    JOURNAL OF HEPATOLOGY
    
    F.J. Munoz-Rodriguez et al., "Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome", J HEPATOL, 30(5), 1999, pp. 770-773
43. Munoz-Rodriguez, FJ; Font, J; Cervera, R; Reverter, JC; Tassies, D; Espinosa, G; Lopez-Soto, A; Carmona, F; Balasch, J; Ordinas, A; Ingelmo, M
    Clinical study and follow-up of 100 patients with the antiphospholipid syndrome
    SEMINARS IN ARTHRITIS AND RHEUMATISM
    
    F.J. Munoz-Rodriguez et al., "Clinical study and follow-up of 100 patients with the antiphospholipid syndrome", SEM ARTH RH, 29(3), 1999, pp. 182-190
44. Montehermoso, A; Cervera, R; Font, J; Ramos-Casals, M; Garcia-Carrasco, M; Formiga, F; Callejas, JL; Jorfan, M; Grino, MC; Ingelmo, M
    Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus
    SEMINARS IN ARTHRITIS AND RHEUMATISM
    
    A. Montehermoso et al., "Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus", SEM ARTH RH, 28(5), 1999, pp. 326-332
45. Takach, TJ; Reul, GJ; Round, ME; Ott, DA; Frazier, OH; Cooley, DA; Cervera, R; Hallman, CL
    Preocclusive carotid artery thrombosis: Pathogenesis and management
    VASCULAR SURGERY
    
    T.J. Takach et al., "Preocclusive carotid artery thrombosis: Pathogenesis and management", VASC SURG, 33(6), 1999, pp. 691-696
46. Cervera, R; Khamashta, MA; Font, J; Sebastiani, GD; Gil, A; Lavilla, P; Aydintug, AO; Jedryka-Goral, A; de Ramon, E; Fernandez-Nebro, A; Galeazzi, M; Haga, HJ; Mathieu, A; Houssiau, F; Ruiz-Irastorza, G; Ingelmo, M; Hughes, GRV
    Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients
    MEDICINE
    
    R. Cervera et al., "Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients", MEDICINE, 78(3), 1999, pp. 167-175
47. Cervera, R; Font, J
    Pregnancy and systemic autoimmune diseases
    MEDICINA CLINICA
    
    R. Cervera e J. Font, "Pregnancy and systemic autoimmune diseases", MED CLIN, 113(20), 1999, pp. 777-778
48. Casals, MR; Garcia-Carrasco, M; Cervera, R; Font, J
    Sjogren syndrome and hepatitis C virus infection
    MEDICINA CLINICA
    
    M.R. Casals et al., "Sjogren syndrome and hepatitis C virus infection", MED CLIN, 112(18), 1999, pp. 718-718
49. Blanco, Y; Ramos-Casals, M; Garcia-Carrasco, M; Cervera, R; Font, J; Ingelmo, M
    Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: report of three new cases and review of the literature
    REVISTA CLINICA ESPANOLA
    
    Y. Blanco et al., "Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: report of three new cases and review of the literature", REV CLIN ES, 199(9), 1999, pp. 586-588
50. Shoenfeld, Y; Cervera, R
    Innovations in autoimmunity in the last decade
    DECADE OF AUTOIMMUNITY
    
    Y. Shoenfeld e R. Cervera, "Innovations in autoimmunity in the last decade", DECADE OF AUTOIMMUNITY, 1999, pp. 7-18
51. RAMOSCASALS M; CERVERA R; FONT J; GARCIACARRASCO M; ESPINOSA G; REINO S; PALLARES L; INGELMO M
    YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICALCHARACTERISTICS
    Lupus
    
    M. Ramoscasals et al., "YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICALCHARACTERISTICS", Lupus, 7(3), 1998, pp. 202-206
52. Ara, J; Vivancos, J; Soler-Carrillo, J; Pare, JC; Cervera, R; Font, J
    Hypertrophic cardiomyopathy and systemic lupus erythematosus
    CLINICAL RHEUMATOLOGY
    
    J. Ara et al., "Hypertrophic cardiomyopathy and systemic lupus erythematosus", CLIN RHEUMA, 17(6), 1998, pp. 531-533
53. GALEAZZI M; BELLISAI F; SEBASTIANI GD; MOROZZI G; MARCOLONGO R; HOUSSIAU F; CERVERA R; LEVY Y; GEORGE J; SHERER Y; SHOENFELD Y
    ASSOCIATION OF 16 6 AND SA1 ANTI-DNA IDIOTYPES WITH ANTICARDIOLIPIN ANTIBODIES AND CLINICAL MANIFESTATIONS IN A LARGE COHORT OF SLE PATIENTS/
    Clinical and experimental rheumatology
    
    M. Galeazzi et al., "ASSOCIATION OF 16 6 AND SA1 ANTI-DNA IDIOTYPES WITH ANTICARDIOLIPIN ANTIBODIES AND CLINICAL MANIFESTATIONS IN A LARGE COHORT OF SLE PATIENTS/", Clinical and experimental rheumatology, 16(6), 1998, pp. 717-720
54. GALEAZZI M; MOROZZI G; SEBASTIANI GD; BELLISAI E; MARCOLONGO R; CERVERA R; GARRIDO ED; FERNANDEZNEBRO A; HOUSSIAU E; JEDRYKAGORAL A; MATHIEU A; PAPASTERIADES C; PIETTE JC; SCORZA R; SMOLEN J
    ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN 566 EUROPEAN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE, CLINICAL ASSOCIATIONS AND CORRELATION WITH OTHER AUTOANTIBODIES
    Clinical and experimental rheumatology
    
    M. Galeazzi et al., "ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN 566 EUROPEAN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE, CLINICAL ASSOCIATIONS AND CORRELATION WITH OTHER AUTOANTIBODIES", Clinical and experimental rheumatology, 16(5), 1998, pp. 541-546
55. JORFEN M; CALLEJAS JL; FORMIGA F; CERVERA R; FONT J; INGELMO M
    FULMINANT THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Scandinavian journal of rheumatology
    
    M. Jorfen et al., "FULMINANT THROMBOTIC THROMBOCYTOPENIC PURPURA IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Scandinavian journal of rheumatology, 27(1), 1998, pp. 76-77
56. Font, J; Ramos-Casals, M; Cervera, R; Bosch, X; Mirapeix, E; Garcia-Carrasco, M; Morla, RM; Ingelmo, M
    Antineutrophil cytoplasmic antibodies in primary Sjogren's syndrome: Prevalence and clinical significance
    BRITISH JOURNAL OF RHEUMATOLOGY
    
    J. Font et al., "Antineutrophil cytoplasmic antibodies in primary Sjogren's syndrome: Prevalence and clinical significance", BR J RHEUM, 37(12), 1998, pp. 1287-1291
57. MIRET C; FONT J; MOLINA R; FILELLA X; VIVANCOS J; MUNOZRODRIGUEZ FJ; CERVERA R; BALLESTA AM; INGELMO M
    LACK OF CORRELATION BETWEEN TUMOR-MARKERS (CA-125 AND SCC) AND SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY
    Anticancer research
    
    C. Miret et al., "LACK OF CORRELATION BETWEEN TUMOR-MARKERS (CA-125 AND SCC) AND SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY", Anticancer research, 18(2B), 1998, pp. 1341-1344
58. Ramos-Casals, M; Cervera, R; Yague, J; Garcia-Carrasco, M; Trejo, O; Jimenez, S; Morla, RM; Font, J; Ingelmo, M
    Cryoglobulinemia in primary Sjogren's syndrome: Prevalence and clinical characteristics in a series of 115 patients
    SEMINARS IN ARTHRITIS AND RHEUMATISM
    
    M. Ramos-Casals et al., "Cryoglobulinemia in primary Sjogren's syndrome: Prevalence and clinical characteristics in a series of 115 patients", SEM ARTH RH, 28(3), 1998, pp. 200-205
59. ASHERSON RA; CERVERA R; PIETTE JC; FONT J; LIE JT; BURCOGLU A; LIM K; MUNOZRODRIGUEZ FJ; LEVY RA; BOUE F; ROSSERT J; INGELMO M
    CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME - CLINICAL AND LABORATORY FEATURES OF 50 PATIENTS
    Medicine
    
    R.A. Asherson et al., "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME - CLINICAL AND LABORATORY FEATURES OF 50 PATIENTS", Medicine, 77(3), 1998, pp. 195-207
60. Font, J; Cervera, R
    Fifty years of LE cells. Is it time for retirement?
    MEDICINA CLINICA
    
    J. Font e R. Cervera, "Fifty years of LE cells. Is it time for retirement?", MED CLIN, 111(19), 1998, pp. 737-738
61. CALLEJAS JL; MUNOZRODRIGUEZ FJ; FORMIGA F; CERVERA R
    CEREBRAL VENOUS THROMBOSIS IN BEHCETS-DIS EASE - MANIFESTATION DESPITE ANTICOAGULANT-THERAPY
    Revista Clinica Espanola
    
    J.L. Callejas et al., "CEREBRAL VENOUS THROMBOSIS IN BEHCETS-DIS EASE - MANIFESTATION DESPITE ANTICOAGULANT-THERAPY", Revista Clinica Espanola, 198(4), 1998, pp. 263-264
62. REVERTER JC; MUNOZ FJ; TASSIES D; FONT J; CERVERA R; LOPEZSOTO A; ESCOLAR G; INGELMO M; ORDINAS A
    ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
    British Journal of Haematology
    
    J.C. Reverter et al., "ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME", British Journal of Haematology, 102(1), 1998, pp. 249-249
63. RAMOSCASALS M; FONT J; PIZCUETA P; CERVERA R; GARCIACARRASCO M; NAVARRO M; JIMENEZ S; INGELMO M; ENGELS P
    INCREASED SERUM LEVELS OF SOLUBLE L-SELECTIN IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS
    Arthritis and rheumatism
    
    M. Ramoscasals et al., "INCREASED SERUM LEVELS OF SOLUBLE L-SELECTIN IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS", Arthritis and rheumatism, 41(9), 1998, pp. 246-246
64. FONT J; MUNOZRODRIGUEZ FJ; CERVERA R; REVERTER JC; LOPEZSOTO A; CARMONA F; BALASCH J; INGELMO M
    ANTIPHOSPHOLIPID SYNDROME - LONG-TERM FOLLOW-UP PROSPECTIVE-STUDY OF A SERIES OF 75 PATIENTS
    Arthritis and rheumatism
    
    J. Font et al., "ANTIPHOSPHOLIPID SYNDROME - LONG-TERM FOLLOW-UP PROSPECTIVE-STUDY OF A SERIES OF 75 PATIENTS", Arthritis and rheumatism, 41(9), 1998, pp. 809-809
65. FONT J; REVERTER JC; KHAMASHTA MA; TASSIES D; CERVERA R; ICHIKAWA K; MONTEAGUDO J; ESCOLAR G; RAMOSCASALS M; MUNOZ FJ; HUGHES GRV; ORDINAS A; INGELMO M
    THE EFFECT OF 3 HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES IN PLATELET INTERACTION WITH A COLLAGEN RICH SURFACE UNDER FLOW CONDITIONS IS BETA-2-GLYCOPROTEIN-I DEPENDENT
    Arthritis and rheumatism
    
    J. Font et al., "THE EFFECT OF 3 HUMAN MONOCLONAL ANTIPHOSPHOLIPID ANTIBODIES IN PLATELET INTERACTION WITH A COLLAGEN RICH SURFACE UNDER FLOW CONDITIONS IS BETA-2-GLYCOPROTEIN-I DEPENDENT", Arthritis and rheumatism, 41(9), 1998, pp. 810-810
66. MUNOZ FJ; FONT J; REVERTER JC; TASSIES D; CERVERA R; RAMOSCASALS M; GARCIACARRASCO M; ESPINOSA G; ORDINAS A; INGELMO M
    ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
    Arthritis and rheumatism
    
    F.J. Munoz et al., "ANTI-PROTHROMBIN ANTIBODIES IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME", Arthritis and rheumatism, 41(9), 1998, pp. 825-825
67. PIETTE JC; MICHEL M; TINCANI A; CERVERA R; SHOENFELD Y; CRASSARD I; BIOUSSE V; MEYER O; TOURNIERLASSERVE E; BOFFA MC
    CHARACTERIZATION OF FAMILIAL, ANTIPHOSPHOLIPID SYNDROME - A EUROPEAN ANTIPHOSPHOLIPID FORUM PROJECT
    Arthritis and rheumatism
    
    J.C. Piette et al., "CHARACTERIZATION OF FAMILIAL, ANTIPHOSPHOLIPID SYNDROME - A EUROPEAN ANTIPHOSPHOLIPID FORUM PROJECT", Arthritis and rheumatism, 41(9), 1998, pp. 843-843
68. FONT J; CARMONA F; CERVERA R; RAMOSCASALS M; MUNOZ FJ; CAYUELA MI; JIMENEZ S; CARARACH V; INGELMO M
    INFLUENCE OF NEPHROPATHY IN THE OUTCOME OF LUPUS PREGNANCY - A COMPARATIVE-STUDY
    Arthritis and rheumatism
    
    J. Font et al., "INFLUENCE OF NEPHROPATHY IN THE OUTCOME OF LUPUS PREGNANCY - A COMPARATIVE-STUDY", Arthritis and rheumatism, 41(9), 1998, pp. 1491-1491
69. FONT J; CERVERA R; RAMOSCASALS M; NONELL F; JIMENEZ S; TREJO O; TORRAS A; INGELMO M; DARNELL A
    THE LONG-TERM OUTCOME OF LUPUS NEPHRITIS - STUDY OF 53 PATIENTS FOLLOWED MORE THAN 10 YEARS IN A SINGLE-CENTER
    Arthritis and rheumatism
    
    J. Font et al., "THE LONG-TERM OUTCOME OF LUPUS NEPHRITIS - STUDY OF 53 PATIENTS FOLLOWED MORE THAN 10 YEARS IN A SINGLE-CENTER", Arthritis and rheumatism, 41(9), 1998, pp. 1492-1492
70. GALEAZZI M; SEBASTIANI GD; ANNUNZIATA P; MATHIEU A; SCORZA R; PAPASTERIADES C; SMOLEN J; HOUSSIAU F; CERVERA R; CAMPANELLA V; MARCOLONGO R
    CLINICAL AND GENETIC ASSOCIATIONS OF ANTI-GM1 ANTIBODIES IN A LARGE SERIES OF EUROPEAN PATIENTS WITH SLE
    Arthritis and rheumatism
    
    M. Galeazzi et al., "CLINICAL AND GENETIC ASSOCIATIONS OF ANTI-GM1 ANTIBODIES IN A LARGE SERIES OF EUROPEAN PATIENTS WITH SLE", Arthritis and rheumatism, 41(9), 1998, pp. 1509-1509
71. GARCIACARRASCO M; CERVERA R; VIDAL J; RAMOSCASSALS M; TREJO O; JIMENEZ S; DELARED G; SISO A; FONT J; INGELMO M
    CYTOPENIA AND PAST HUMAN PARVOVIRUS B19 INFECTION IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME
    Arthritis and rheumatism
    
    M. Garciacarrasco et al., "CYTOPENIA AND PAST HUMAN PARVOVIRUS B19 INFECTION IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME", Arthritis and rheumatism, 41(9), 1998, pp. 1765-1765
72. GARCIACARRASCO M; RAMOSCASALS M; ROSAS J; JIMENEZ S; TREJO O; DELARED G; CERVERA R; FONT J; INGELMO M
    PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS IN A SERIES OF 210 PATIENTS
    Arthritis and rheumatism
    
    M. Garciacarrasco et al., "PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS IN A SERIES OF 210 PATIENTS", Arthritis and rheumatism, 41(9), 1998, pp. 1766-1766
73. RAMOSCASALS M; CERVERA R; GAYA J; GARCIACARRASCO M; MORLA RM; TREJO O; DELARED G; FONT J; INGELMO M
    SUBCLINICAL THYROID-DISEASE IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME - ANALYSIS OF 130 PATIENTS WITHOUT PREVIOUS EVIDENCE OF THYROID INVOLVEMENT
    Arthritis and rheumatism
    
    M. Ramoscasals et al., "SUBCLINICAL THYROID-DISEASE IN PATIENTS WITH PRIMARY SJOGRENS-SYNDROME - ANALYSIS OF 130 PATIENTS WITHOUT PREVIOUS EVIDENCE OF THYROID INVOLVEMENT", Arthritis and rheumatism, 41(9), 1998, pp. 1773-1773
74. REVERTER JC; TASSIES D; FONT J; KHAMASHTA MA; ICHIKAWA K; CERVERA R; ESCOLAR G; HUGHES GRV; INGELMO M; ORDINAS A
    EFFECTS OF HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODIES ON PLATELET-FUNCTION AND ON TISSUE FACTOR EXPRESSION ON MONOCYTES
    Arthritis and rheumatism
    
    J.C. Reverter et al., "EFFECTS OF HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODIES ON PLATELET-FUNCTION AND ON TISSUE FACTOR EXPRESSION ON MONOCYTES", Arthritis and rheumatism, 41(8), 1998, pp. 1420-1427
75. FONT J; CERVERA R; ESPINOSA G; PALLARES L; RAMOSCASALS M; JIMENEZ S; GARCIACARRASCO M; SEISDEDOS L; INGELMO M
    SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) IN CHILDHOOD - ANALYSIS OF CLINICAL AND IMMUNOLOGICAL FINDINGS IN 34 PATIENTS AND COMPARISON WITH SLE CHARACTERISTICS IN ADULTS
    Annals of the Rheumatic Diseases
    
    J. Font et al., "SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) IN CHILDHOOD - ANALYSIS OF CLINICAL AND IMMUNOLOGICAL FINDINGS IN 34 PATIENTS AND COMPARISON WITH SLE CHARACTERISTICS IN ADULTS", Annals of the Rheumatic Diseases, 57(8), 1998, pp. 456-459
76. FONT J; TASSIES D; GARCIACARRASCO M; RAMOSCASALS M; CERVERA R; REVERTER JC; SANCHEZTAPIAS J; MAZZARA R; INGELMO M
    HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS
    Annals of the Rheumatic Diseases
    
    J. Font et al., "HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS", Annals of the Rheumatic Diseases, 57(1), 1998, pp. 42-44
77. NAVARRO M; CERVERA R; FONT J; REVERTER JC; MONTEAGUDO J; ESCOLAR G; LOPEZSOTO A; ORDINAS A; INGELMO M
    ANTIENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC AUTOIMMUNE-DISEASES - PREVALENCE AND CLINICAL-SIGNIFICANCE
    Lupus
    
    M. Navarro et al., "ANTIENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC AUTOIMMUNE-DISEASES - PREVALENCE AND CLINICAL-SIGNIFICANCE", Lupus, 6(6), 1997, pp. 521-526
78. MUNOZRODRIGUEZ FJ; FONT J; BADIA JR; MIRET C; BARBERA JA; CERVERA R; INGELMO M
    SHRINKING LUNGS SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPROVEMENT WITH INHALED BETA-AGONIST THERAPY
    Lupus
    
    F.J. Munozrodriguez et al., "SHRINKING LUNGS SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPROVEMENT WITH INHALED BETA-AGONIST THERAPY", Lupus, 6(4), 1997, pp. 412-414
79. SEISDEDOS L; MUNOZRODRIGUEZ FJ; CERVERA R; FONT J; INGELMO M
    PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS
    Lupus
    
    L. Seisdedos et al., "PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS", Lupus, 6(3), 1997, pp. 285-286
80. REINO S; MUNOZRODRIGUEZ FJ; CERVERA R; ESPINOSA G; FONT J; INGELMO M
    OPTIC NEUROPATHY IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - REPORT OFA CASE AND REVIEW OF THE LITERATURE
    Clinical rheumatology
    
    S. Reino et al., "OPTIC NEUROPATHY IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - REPORT OFA CASE AND REVIEW OF THE LITERATURE", Clinical rheumatology, 16(6), 1997, pp. 629-631
81. MIRET C; CERVERA R; REVERTER JC; GARCIACARRASCO M; RAMOS M; MOLLA M; FONT J; INGELMO M
    ANTIPHOSPHOLIPID SYNDROME WITHOUT ANTIPHOSPHOLIPID ANTIBODIES AT THE TIME OF THE THROMBOTIC EVENT - TRANSIENT SERONEGATIVE ANTIPHOSPHOLIPIDSYNDROME
    Clinical and experimental rheumatology
    
    C. Miret et al., "ANTIPHOSPHOLIPID SYNDROME WITHOUT ANTIPHOSPHOLIPID ANTIBODIES AT THE TIME OF THE THROMBOTIC EVENT - TRANSIENT SERONEGATIVE ANTIPHOSPHOLIPIDSYNDROME", Clinical and experimental rheumatology, 15(5), 1997, pp. 541-544
82. CERVERA R; GARCIACARRASCO M; FONT J; RAMOS M; REVERTER JC; MUNOZ FJ; MIRET C; ESPINOSA G; INGELMO M
    ANTIPHOSPHOLIPID ANTIBODIES IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 80 PATIENTS
    Clinical and experimental rheumatology
    
    R. Cervera et al., "ANTIPHOSPHOLIPID ANTIBODIES IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 80 PATIENTS", Clinical and experimental rheumatology, 15(4), 1997, pp. 361-365
83. LOPEZSOTO A; CERVERA R; FONT J; BOVE A; REVERTER JC; MUNOZ FJ; MIRET C; ESPINOSA G; ORDINAS A; INGELMO M
    ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO CARDIOLIPIN, PHOSPHATIDIC-ACID, PHOSPHATIDYLINOSITOL AND PHOSPHATIDYLSERINEIN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF92 PATIENTS
    Clinical and experimental rheumatology
    
    A. Lopezsoto et al., "ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO CARDIOLIPIN, PHOSPHATIDIC-ACID, PHOSPHATIDYLINOSITOL AND PHOSPHATIDYLSERINEIN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF92 PATIENTS", Clinical and experimental rheumatology, 15(2), 1997, pp. 143-149
84. TEIXIDO M; FONT J; REVERTER JC; CERVERA R; TASSIES D; INGELMO M; ESCOLAR G; ORDINAS A
    ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES - A USEFUL MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME
    British journal of rheumatology
    
    M. Teixido et al., "ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES - A USEFUL MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME", British journal of rheumatology, 36(1), 1997, pp. 113-116
85. FONT J; LOPEZSOTO A; CERVERA R; CASALS FJ; REVERTER JC; MUNOZ FJ; MIRET C; BOVE A; ORDINAS A; INGELMO M
    ANTIBODIES TO THROMBOPLASTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE IN A SERIES OF 92 PATIENTS
    Thrombosis research
    
    J. Font et al., "ANTIBODIES TO THROMBOPLASTIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ISOTYPE DISTRIBUTION AND CLINICAL-SIGNIFICANCE IN A SERIES OF 92 PATIENTS", Thrombosis research, 86(1), 1997, pp. 37-48
86. CERVERA R; ASHERSON RA; FONT J; TIKLY M; PALLARES L; CHAMORRO A; INGELMO M
    CHOREA IN THE ANTIPHOSPHOLIPID-SYNDROME - CLINICAL, RADIOLOGIC, AND IMMUNOLOGICAL CHARACTERISTICS OF 50 PATIENTS FROM OUR CLINICS AND THE RECENT LITERATURE
    Medicine
    
    R. Cervera et al., "CHOREA IN THE ANTIPHOSPHOLIPID-SYNDROME - CLINICAL, RADIOLOGIC, AND IMMUNOLOGICAL CHARACTERISTICS OF 50 PATIENTS FROM OUR CLINICS AND THE RECENT LITERATURE", Medicine, 76(3), 1997, pp. 203-212
87. CERVERA R; FONT J
    UVEITIS AND SYSTEMIC-DISEASES
    Medicina Clinica
    
    R. Cervera e J. Font, "UVEITIS AND SYSTEMIC-DISEASES", Medicina Clinica, 109(20), 1997, pp. 792-794
88. RAMOS M; CERVERA R; GARCIACARRASCO M; FONT J
    CLINICAL MANIFESTATIONS OF PRIMARY SJOGREN SYNDROME
    Medicina Clinica
    
    M. Ramos et al., "CLINICAL MANIFESTATIONS OF PRIMARY SJOGREN SYNDROME", Medicina Clinica, 109(18), 1997, pp. 730-730
89. RAMOS M; CERVERA R; GARCIACARRASCO M; MIRET C; MUNOZ FJ; ESPINOSA G; FONT J; INGELMO M
    PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL STUDY OF 80 PATIENTS
    Medicina Clinica
    
    M. Ramos et al., "PRIMARY SJOGRENS-SYNDROME - CLINICAL AND IMMUNOLOGICAL STUDY OF 80 PATIENTS", Medicina Clinica, 108(17), 1997, pp. 652-657
90. CERVERA R; FONT J; SEBASTIANI GD; KHAMASHTA MA; HUGHES GRV
    EURO-LUPUS PROJECT - 5-YEAR PROSPECTIVE-STUDY OF MORBIDITY AND MORTALITY IN A COHORT OF 1000 PATIENTS WITH SLE
    Arthritis and rheumatism
    
    R. Cervera et al., "EURO-LUPUS PROJECT - 5-YEAR PROSPECTIVE-STUDY OF MORBIDITY AND MORTALITY IN A COHORT OF 1000 PATIENTS WITH SLE", Arthritis and rheumatism, 40(9), 1997, pp. 779-779
91. FONT J; BAHIA D; RAMOS M; CERVERA R; BACHELIAS M; ESPUNY R; KHAOUJA A; CICARELLI RMB; INGELMO M
    THE CONSERVED SM-MOTIF-1 IS AN EPITOPE BROADLY RECOGNIZED BY AUTOANTIBODIES FROM SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    Arthritis and rheumatism
    
    J. Font et al., "THE CONSERVED SM-MOTIF-1 IS AN EPITOPE BROADLY RECOGNIZED BY AUTOANTIBODIES FROM SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS", Arthritis and rheumatism, 40(9), 1997, pp. 798-798
92. RAMOS M; FONT J; CERVERA R; GARCIACARRASCO M; ESPINOSA G; TREJO O; INGELMO M
    HIGH-RISK OF DEVELOPMENT OF LYMPHOPROLIFERATIVE MALIGNANCIES IN PATIENTS WITH YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME
    Arthritis and rheumatism
    
    M. Ramos et al., "HIGH-RISK OF DEVELOPMENT OF LYMPHOPROLIFERATIVE MALIGNANCIES IN PATIENTS WITH YOUNG ONSET OF PRIMARY SJOGRENS-SYNDROME", Arthritis and rheumatism, 40(9), 1997, pp. 1038-1038
93. FONT J; TASSIES D; RAMOS M; GARCIACARRASCO M; CERVERA R; REVERTER JC; SANCHEZTAPIAS JM; JIMENEZ S; TREJO O; INGELMO M
    HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS
    Arthritis and rheumatism
    
    J. Font et al., "HEPATITIS-G VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - ANALYSIS IN A SERIES OF 100 PATIENTS", Arthritis and rheumatism, 40(9), 1997, pp. 1046-1046
94. MONTEHERMOSO A; CERVERA R; FONT J; RAMOS M; CALLEJAS JL; MUNOZ FJ; JIMENEZ S; INGELMO M
    ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH RETINAL VASCULAR-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Arthritis and rheumatism
    
    A. Montehermoso et al., "ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH RETINAL VASCULAR-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Arthritis and rheumatism, 40(9), 1997, pp. 1619-1619
95. GARCIACARRASCO M; RAMOS M; CERVERA R; FONT J; VIDAL J; MUNOZ FJ; MIRET C; ESPINOSA G; INGELMO M
    HEPATITIS-C VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 90 PATIENTS
    Annals of the Rheumatic Diseases
    
    M. Garciacarrasco et al., "HEPATITIS-C VIRUS-INFECTION IN PRIMARY SJOGRENS-SYNDROME - PREVALENCEAND CLINICAL-SIGNIFICANCE IN A SERIES OF 90 PATIENTS", Annals of the Rheumatic Diseases, 56(3), 1997, pp. 173-175
96. NAVARRO M; CERVERA R; TEIXIDO M; REVERTER JC; FONT J; LOPEZSOTO A; MONTEAGUDO J; ESCOLAR G; INGELMO M
    ANTIBODIES TO ENDOTHELIAL-CELLS AND TO BETA-2-GLYCOPROTEIN-I IN THE ANTIPHOSPHOLIPID SYNDROME - PREVALENCE AND ISOTYPE DISTRIBUTION
    British journal of rheumatology
    
    M. Navarro et al., "ANTIBODIES TO ENDOTHELIAL-CELLS AND TO BETA-2-GLYCOPROTEIN-I IN THE ANTIPHOSPHOLIPID SYNDROME - PREVALENCE AND ISOTYPE DISTRIBUTION", British journal of rheumatology, 35(6), 1996, pp. 523-528
97. MANZANARES JM; CONGET I; RODRIGUEZVILLAR C; TASSIES D; FERNANDEZFERNANDEZ F; CERVERA R; LEVY I; GOMIS R
    ANTIPHOSPHOLIPID SYNDROME IN A PATIENT WITH TYPE-I DIABETES PRESENTING AS RETINAL ARTERY-OCCLUSION
    Diabetes care
    
    J.M. Manzanares et al., "ANTIPHOSPHOLIPID SYNDROME IN A PATIENT WITH TYPE-I DIABETES PRESENTING AS RETINAL ARTERY-OCCLUSION", Diabetes care, 19(1), 1996, pp. 92-94
98. MOLLA M; MIRET C; SARASA B; CERVERA R
    BACTEREMIA BY ACHROMOBACTER XYLOSIDANS
    Medicina Clinica
    
    M. Molla et al., "BACTEREMIA BY ACHROMOBACTER XYLOSIDANS", Medicina Clinica, 106(1), 1996, pp. 38-38
99. GARCIACARRASCO M; RAMOS M; CERVERA R; VIDAL J; MUNOZ FJ; ESPINOSA G; FONT J; INGELMO M
    HEPATITIS-C VIRUS-INFECTION IN PRIMARY SJOGREN SYNDROME - PREVALENCE AND CLINICAL-SIGNIFICANCE IN A SERIES OF 90 PATIENTS
    Arthritis and rheumatism
    
    M. Garciacarrasco et al., "HEPATITIS-C VIRUS-INFECTION IN PRIMARY SJOGREN SYNDROME - PREVALENCE AND CLINICAL-SIGNIFICANCE IN A SERIES OF 90 PATIENTS", Arthritis and rheumatism, 39(9), 1996, pp. 1035-1035
100. ROSARE D; GARCIA F; GASCON J; ANGRILL J; CERVERA R
     QUININE-INDUCED LUPUS-LIKE SYNDROME AND CARDIOLIPIN ANTIBODIES
     Annals of the Rheumatic Diseases
     
     D. Rosare et al., "QUININE-INDUCED LUPUS-LIKE SYNDROME AND CARDIOLIPIN ANTIBODIES", Annals of the Rheumatic Diseases, 55(8), 1996, pp. 559-560